ABZENA
LIVE

Serial Number

86234440

Owner

ABZENA (UK) LIMITED

Attorney

Mainak H. Mehta

Filing Date

Mar 27, 2014

Add to watchlist:

No watchlists yet
View on USPTO

ABZENA Trademark

Serial Number: 86234440 • Registration: 4737716

ABZENA is a trademark filed by ABZENA (UK) LIMITED on March 27, 2014. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

ABZENA (UK) LIMITED (9 trademarks)

900 BABRAHAM RESEARCH CAMPUS, BABRAHAM
CAMBRIDGE CB22 3AT , GB

Entity Type: 24

PolyTherics Ltd.

London Bioscience Innovation Centre
London NW10NH , GB

Entity Type: 99

Trademark Details

Filing Date

March 27, 2014

Registration Date

May 19, 2015

Published for Opposition

March 3, 2015

Goods & Services

Pharmaceuticals, pharmaceutical compositions, and pharmaceutical preparations, used to treat cancer, diseases of the immune system, viral infections, HIV, Influenza, inflammatory diseases, fibrotic diseases, pulmonary diseases, blood disorders, neurodegenerative diseases, graft rejection; chemical preparations for medical or pharmaceutical purposes, namely, chemicals sold as integral component parts of pharmaceutical preparations for the treatment of cancer, diseases of the immune system, viral infections, HIV, Influenza, inflammatory diseases, fibrotic diseases, pulmonary diseases, blood disorders, neurodegenerative diseases, graft rejection; chemico-pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of cancer, diseases of the immune system, viral infections, HIV, Influenza, inflammatory diseases, fibrotic diseases, pulmonary diseases, blood disorders, neurodegenerative diseases, graft rejection

Chemicals for use in manufacturing pharmaceuticals; Chemical preparations for use in the manufacture of pharmaceuticals; Chemicals for use in the pharmaceutical industry; chemicals for use in the pharmaceutical industry, namely, intermediates for pharmaceuticals; intermediates being chemicals for use in industry, namely, chemicals for use in the manufacture of pharmaceuticals

Medical services, namely, providing medical information regarding pharmaceuticals; pharmaceutical services and provision of pharmaceutical information, all in the nature of providing medical information regarding pharmaceuticals; providing to others a collection of information, namely, providing medical information relating to the use of pharmaceuticals

Scientific research and product development services in relation to pharmaceutical and medical products; scientific services, namely, product development in the field of pharmaceuticals; research, namely, scientific research and product development in the field of pharmaceuticals; industrial research in the field of pharmaceuticals; product design in the field of pharmaceuticals; Pharmaceutical research services; Pharmaceutical product evaluation; Testing of pharmaceuticals; Pharmaceutical drug development services; Development of pharmaceutical preparations and medicines; Providing medical and scientific research information in the field of pharmaceuticals; provision of scientific information in the fields of cancer, diseases of the immune system, viral infections, HIV, Influenza, inflammatory diseases, fibrotic diseases, pulmonary diseases, blood disorders, neurodegenerative diseases, graft rejection; providing of scientific information regarding pharmaceuticals and medicines; provision of scientific information relating to the chemical industry, namely, information on the subject of chemical product development

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Sep 9, 2025 NA89
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Sep 9, 2025 RNL1
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Sep 9, 2025 89AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sep 9, 2025 APRE
TEAS SECTION 8 & 9 RECEIVED
May 9, 2025 E89R
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
May 19, 2024 REM2
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Sep 21, 2021 NAS8
REGISTERED - SEC. 8 (6-YR) ACCEPTED
Sep 21, 2021 8.OK
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sep 21, 2021 APRE
TEAS SECTION 8 RECEIVED
May 18, 2021 ES8R
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
May 19, 2020 REM1
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jul 31, 2019 ASGN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 4, 2016 TCCA
REGISTERED-PRINCIPAL REGISTER
May 19, 2015 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 3, 2015 NPUB
PUBLISHED FOR OPPOSITION
Mar 3, 2015 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 11, 2015 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jan 23, 2015 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 22, 2015 CNSA
EXAMINER'S AMENDMENT ENTERED
Jan 22, 2015 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 22, 2015 GNEN
EXAMINERS AMENDMENT E-MAILED
Jan 22, 2015 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jan 22, 2015 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 21, 2015 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 20, 2015 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 20, 2015 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 15, 2014 GNRN
NON-FINAL ACTION E-MAILED
Dec 15, 2014 GNRT
NON-FINAL ACTION WRITTEN
Dec 15, 2014 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 24, 2014 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 24, 2014 CRFA
ASSIGNED TO LIE
Nov 24, 2014 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 20, 2014 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 28, 2014 GNRN
NON-FINAL ACTION E-MAILED
Jun 28, 2014 GNRT
NON-FINAL ACTION WRITTEN
Jun 28, 2014 CNRT
ASSIGNED TO EXAMINER
Jun 28, 2014 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 10, 2014 NWOS
NEW APPLICATION ENTERED
Mar 31, 2014 NWAP